Political Storm Clouds Gather Over BioNTech’s Vaccine Business
Published on 09/14/2025 at 21:09 | Redaktion boerse-global.deA bombshell report from the Washington Post triggered a dramatic selloff in BioNTech shares this week, wiping out gains from positive oncology developments and casting a shadow over the company’s core vaccine operations. The selloff was sparked by revelations that health officials within the Trump administration are preparing to link COVID-19 vaccines to child fatalities.
According to the report, government officials intend to present findings connecting COVID-19 vaccines to 25 unconfirmed child fatalities to a CDC advisory committee as early as next week. The purported evidence is said to be based on unverified reports from the Vaccine Adverse Event Reporting System—a move that has reportedly alarmed veteran scientists within the medical community.
The market’s reaction was severe. BioNTech’s stock plummeted more than 7% on... Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
